Brief: WuXi AppTec's Long Position In JW Cayman Therapeutics Falls To 3.80% - HKEX Filing
July 5 (Reuters) - Hong Kong stock exchange filing:
* WUXI APPTEC CO LTD'S LONG POSITION IN JW (CAYMAN)
THERAPEUTICS
2126.HK REDUCED TO 3.80% ON JULY 2 FROM 9.54% - HKEX FILING
Source text in English: https://bit.ly/3xvVTk1
Further company coverage: 2126.HK 2359.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on JW (Cayman) Therapeutics Co
See all newsChina pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Brief: JW (Cayman) Therapeutics Appoints Tian Feng As CEO, Executive Director
Australia's Imugene gains on alliance with JW Therapeutics for tumour treatment
Brief: JW (Cayman) Therapeutics H1 Net Income RMB -267.3 Million
Brief: JW (Cayman) Therapeutics Grants Juno Therapeutics Non-Exclusive License